Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
24.42
+0.08 (0.33%)
Nov 20, 2024, 4:00 PM EST - Market closed
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.51 billion as of November 21, 2024. Its market cap has increased by 23.25% in one year.
Market Cap
3.51B
Enterprise Value
2.29B
1-Year Change
23.25%
Ranking
Category
Stock Price
$24.42
Market Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.51B, an increase of 86.24%. That is a compound annual growth rate of 9.36%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Option Care Health | 3.72B |
| Perrigo Company | 3.70B |
| DENTSPLY SIRONA | 3.68B |
| Rhythm Pharmaceuticals | 3.65B |
| Acadia Healthcare Company | 3.63B |
| Envista Holdings | 3.51B |
| Apellis Pharmaceuticals | 3.42B |
| ImmunityBio | 3.40B |